Varex Imaging Corporation (NASDAQ:VREX) is expected to report fourth quarter earnings results, after market close, on Tuesday 17th November 2020.
Analysts polled by Thomson Reuters anticipate fourth quarter loss of $ 0.1 per share.
Looking ahead, the full year income are expected at $ 0.02 per share on the revenues of $ 730.34 million.
The Company Outlook
Revenue for 4Q20 are expected in a range of $ 155.00 million ~ $ 170.00 million
Full Year 2020 topline are forecasted in a range of$ 790.00 million ~ $ 805.00 million, where as bottomline are predicted in a range of $ 1.30 ~ $ 1.45 per share
Click Here For More Historical Outlooks Of Varex Imaging Corporation
Previous Quarter Performance
Varex Imaging Corporation recorded loss for the third quarter of $ 0.20 per share, from the revenue of $ 171.20 million. Wall street analysts are predicting, VREX to report 3Q20 loss of $ 0.01 per share from revenue of $ 171.09 million. The top line results outshined analysts by $ 0.11 million or 0.06 percent.
Stock Performance
Shares of Varex Imaging Corporation traded up $ 0.05 or 0.34 percent on Monday, reaching $ 14.62 with volume of 323.30 thousand shares. Varex Imaging Corporation has traded high as $ 15.36 and has cracked $ 14.49 on the downward trend
According to the previous trading day, closing price of $ 14.62, representing a 40.50 % increase from the 52 week low of $ 10.37 and a 54.77 % decrease over the 52 week high of $ 32.21.
The company has a market capital of $ 571.64 million and is part of the Healthcare sector and Diagnostics & Research industry.
Conference Call
Varex Imaging Corporation will be hosting a conference call at 5:00 PM eastern time on 17th November 2020, to discuss its 4Q20 financial results with the investment community. The participants may dial, 1-877-524-8416 (United States) or 1-412-902-1028 Outside U.S. in order to access the live audio call. A live webcast with presentations will be available on the Internet by visiting the Company website www.vareximaging.com
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, ionization chambers, and buckys.
